New drug duo tested in battle against advanced vulvar cancer
NCT ID NCT07290894
Summary
This study is testing whether a combination of two existing drugs, pembrolizumab and lenvatinib, can help control advanced vulvar cancer. It will enroll 80 women whose cancer cannot be removed by surgery, has come back, or has spread. The main goals are to see if the treatment shrinks tumors and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVA CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nation Cancer Institute of Naples, Division of Medical Oncology - Uro-Gynecology Department, Naples
Naples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.